SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899866-17-000027
Filing Date
2017-02-08
Accepted
2017-02-08 16:39:44
Documents
1
Period of Report
2017-02-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_148658996992757.html 4  
1 FORM 4 wf-form4_148658996992757.xml 4 5586
  Complete submission text file 0000899866-17-000027.txt   6939
Mailing Address 100 COLLEGE STREET NEW HAVEN CT 06510
Business Address 100 COLLEGE STREET NEW HAVEN CT 06510 2032722596
ALEXION PHARMACEUTICALS INC (Issuer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ALEXION PHARMACEUTICALS, INC 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
Miller Edward (Reporting) CIK: 0001619252 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27756 | Film No.: 17583066